| 2025-03-31 07:00 | CC:LABS | MEDIPHARM LABS CORP. J | 0.10 | News Release200 | MediPharm Labs Reports Full Year & Fourth Quarter 2024 Results |
| 2025-03-31 04:10 | CC:LABS | Medipharm Labs Corp | 0.10 | SEDAR Annual Information Form802 | SEDAR Annual Information Form |
| 2025-03-31 04:09 | CC:LABS | Medipharm Labs Corp | 0.10 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
| 2025-03-31 04:09 | CC:LABS | Medipharm Labs Corp | 0.10 | SEDAR MD & A815 | SEDAR MD & A |
| 2025-03-26 10:39 | CC:LABS | Medipharm Labs Corp | 0.10 | News Release200 | Medipharm Labs to release fiscal 2024 results March 31 |
| 2025-02-10 16:14 | CC:LABS | Medipharm Labs Corp | 0.07 | News Release200 | Medipharm cancels Napanee facility sale to Kensana |
| 2025-01-16 16:21 | CC:LABS | Medipharm Labs Corp | 0.07 | News Release200 | Medipharm extends closing of Napanee sale to Jan. 31 |
| 2025-01-08 16:57 | CC:LABS | Medipharm Labs Corp | 0.075 | News Release200 | Medipharm Labs signs commercial agreement with Teuto |
| 2024-12-17 16:30 | CC:LABS | Medipharm Labs Corp | 0.065 | News Release200 | Medipharm agrees to sell Napanee facility for $5.5M |
| 2024-11-14 07:00 | CC:LABS | MEDIPHARM LABS CORP. J | 0.08 | News Release200 | MediPharm Labs Reports Third Quarter Results |
| 2024-11-14 06:59 | CC:LABS | Medipharm Labs Corp | 0.08 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2024-11-14 06:59 | CC:LABS | Medipharm Labs Corp | 0.08 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2024-11-11 07:44 | CC:LABS | Medipharm Labs Corp | 0.07 | News Release200 | Medipharm Labs to release Q3 2024 results Nov. 14 |
| 2024-10-17 15:33 | CC:LABS | Medipharm Labs Corp | 0.075 | News Release200 | Medipharm Labs president, co-founder Strachan resigns |
| 2024-09-17 10:57 | CC:LABS | Medipharm Labs Corp | 0.06 | News Release200 | Medipharm Labs repays $2.1-million convertible debt |
| 2024-08-14 07:10 | CC:LABS | Medipharm Labs Corp | 0.07 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2024-08-14 07:10 | CC:LABS | Medipharm Labs Corp | 0.07 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2024-08-14 07:00 | CC:LABS | MEDIPHARM LABS CORP. J | 0.07 | News Release200 | MediPharm Labs Reports Second Quarter Results Closing in on Positive Adjusted EBITDA(1) as Gross Profit Continues to Improve |
| 2024-08-08 16:59 | CC:LABS | Medipharm Labs Corp | 0.07 | News Release200 | Medipharm Labs to release Q2 results Aug. 14 |
| 2024-06-26 17:29 | CC:LABS | Medipharm Labs Corp | 0.075 | News Release200 | Medipharm Labs shareholders approve AGM resolutions |
| 2024-06-20 10:07 | CC:LABS | Medipharm Labs Corp | 0.07 | News Release200 | Medipharm Labs licenses technology from Remidose |
| 2024-05-15 10:30 | CC:LABS | Medipharm Labs Corp | 0.08 | News Release200 | Medipharm Labs talks revenue, omits Q1 P&L from NR |
| 2024-05-15 07:12 | CC:LABS | Medipharm Labs Corp | 0.085 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2024-05-15 07:05 | CC:LABS | Medipharm Labs Corp | 0.085 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2024-05-08 16:42 | CC:LABS | Medipharm Labs Corp | 0.085 | News Release200 | Medipharm Labs to release Q1 results May 15 |